In April, 2018, the FDA approved a cloud-based software program that uses Artificial Intelligence (Al) to provide a screening decision in diabetic retinopathy without the need for a clinician to interpret the mane or results
Al is now used routinely for rapid, accurate, and objective diagnosis of eye disease
A Congress on Artificial Intelligence and the Eye
Hosted by SOA-Canada
This on-site, multidisciplinary conference in Toronto will update the clinician on the current state of Al in ophthalmology and optometry, as well as highlight promising areas of research and development
The conference will be followed by a gala dinner in honour of the St John of Jerusalem Eye Hospital
Guests who purchase dinner tickets will receive a charitable tax receipt from St John Ambulance Canada
(Registered Charity #89903 4730 RR0001)
This conference is part of a series hosted by the Ophthalmic Association of St John of Jerusalem Eye Hospital Group
PROGRAMME
